MS

Mandeep Singh

Active Director Director DIN 08707124
DIN 08707124 First appointment Mar 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Mar 2020
Shareholding value •••• Premium profile

About Mandeep Singh

Data last updated:

Mandeep Singh is a Director at Katyayani Hospitals Private Limited (since 2020), Director at Sbr Radiology Private Limited (since 2021) and Director at Metrocity Medicalcare Private Limited (since 2021), and holds 2 more current directorships. The companies operate in Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹11.06 Cr; the largest is Katyayani Hospitals Private Limited at ₹7.51 Cr (FY 2025). Earlier, Mandeep Singh was a Director at Psychmantra Private Limited (2021–2022).

DIN 08707124
Primary Designation Director
Industry Healthcare
First Appointment 24 Mar 2020
Oldest Company Age 6 yrs
Largest company Katyayani Hospitals Private Limited · ₹7.51 Cr (FY 2025)
Combined revenue ₹11.06 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Katyayani Hospitals Private Limited U85100UR2020PTC010889
Director24 Mar 20202020₹7.51 Cr (FY 2025)Active
Sbr Radiology Private Limited U74999UR2020PTC011615
Director16 Feb 20212020₹2.08 Cr (FY 2025)Active
Director08 Sep 20212021₹1.47 Cr (FY 2024)Active
Designated Partner25 Jun 20252025Active
Katyayani Meds Private Limited U47721UT2024PTC017758
Director23 Jul 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Psychmantra Private Limited U85300UR2021PTC012622
Director08 Jul 20212021₹1.63 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sbr Radiology Private Limited
Katyayani Hospitals Private Limited
Metrocity Medicalcare Private Limited
Indra Home Health Care Llp
Premium access

Shareholding and investment profile for Mandeep Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mandeep Singh

Mandeep Singh currently holds 5 directorships: Katyayani Hospitals Private Limited (Director, since 24 Mar 2020, revenue ₹7.51 Cr (FY 2025)); Sbr Radiology Private Limited (Director, since 16 Feb 2021, revenue ₹2.08 Cr (FY 2025)); Metrocity Medicalcare Private Limited (Director, since 08 Sep 2021, revenue ₹1.47 Cr (FY 2024)); Indra Home Health Care Llp (Designated Partner, since 25 Jun 2025); Katyayani Meds Private Limited (Director, since 23 Jul 2024).

Mandeep Singh was first appointed on 24 Mar 2020 as Director at Katyayani Hospitals Private Limited. The most recent appointment on record is 25 Jun 2025 at Indra Home Health Care Llp.

The 3 current companies of Mandeep Singh that report revenue have a combined latest revenue of ₹11.06 Cr: Katyayani Hospitals Private Limited ₹7.51 Cr (FY 2025); Sbr Radiology Private Limited ₹2.08 Cr (FY 2025); Metrocity Medicalcare Private Limited ₹1.47 Cr (FY 2024).

Mandeep Singh held 1 earlier board appointment: Psychmantra Private Limited (Director, 08 Jul 2021 to 19 Sep 2022).

The current boards of Mandeep Singh's companies include Ajay Kumar Arora (Katyayani Hospitals Private Limited), Deep Chilana (Katyayani Hospitals Private Limited), Jasvinder Singh (Katyayani Hospitals Private Limited), Mandeep Kaur (Katyayani Hospitals Private Limited), Manpreet Anand (Katyayani Hospitals Private Limited), Nitik Bathla (Katyayani Hospitals Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available